{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T03:07:09Z","timestamp":1763867229863,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005852","name":"Research Institute for Dental Sciences, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00784-018-2579-7","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T05:04:50Z","timestamp":1536123890000},"page":"1803-1809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immediate implant placement following 1-year treatment with oral versus intravenous bisphosphonates: a histomorphometric canine study on peri-implant bone"],"prefix":"10.1007","volume":"23","author":[{"given":"Arash","family":"Khojasteh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mehdi","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantea","family":"Nazeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"2579_CR1","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1097\/SCS.0b013e31827009c5","volume":"24","author":"A Khojasteh","year":"2013","unstructured":"Khojasteh A, Behnia H, Morad G, Dashti SG, Dehghan MM, Shahab S, Abbas FM (2013) Healing of extraction sockets and augmented alveolar defects following 1-year treatment with bisphosphonate. J Craniofac Surg 24:e68\u2013e73","journal-title":"J Craniofac Surg"},{"key":"2579_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/2155-8213.183767","volume":"7","author":"P Nazeman","year":"2016","unstructured":"Nazeman P, Rad MR, Khojasteh A (2016) Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw. Dental Hypotheses 7:56","journal-title":"Dental Hypotheses"},{"key":"2579_CR3","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032\u20131045","journal-title":"Mayo Clin Proc"},{"key":"2579_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"2579_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","volume":"35","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J 35:119\u2013130","journal-title":"Aust Endod J"},{"key":"2579_CR6","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/jnci\/djm025","volume":"99","author":"GS Wilkinson","year":"2007","unstructured":"Wilkinson GS, Kuo Y-F, Freeman JL, Goodwin JS (2007) Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. J Natl Cancer Inst 99:1016\u20131024","journal-title":"J Natl Cancer Inst"},{"key":"2579_CR7","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27:5356\u20135362","journal-title":"J Clin Oncol"},{"key":"2579_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"2579_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"key":"2579_CR10","unstructured":"Saad F, Brown J, Van Poznak C, Ibrahim T, Stemmer S, Stopeck AT, Diel I, Takahashi S, Shore N, Henry D (2011) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol:mdr435"},{"key":"2579_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","volume":"112","author":"T Fehm","year":"2009","unstructured":"Fehm T, Beck V, Banys M, Lipp HP, Hairass M, Reinert S, Solomayer EF, Wallwiener D, Krimmel M (2009) Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies. Gynecol Oncol 112:605\u2013609","journal-title":"Gynecol Oncol"},{"key":"2579_CR12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.joms.2010.07.026","volume":"69","author":"M Scoletta","year":"2011","unstructured":"Scoletta M, Arduino PG, Pol R, Arata V, Silvestri S, Chiecchio A, Mozzati M (2011) Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report. J Oral Maxillofac Surg 69:456\u2013462","journal-title":"J Oral Maxillofac Surg"},{"key":"2579_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1708-8208.2009.00150.x","volume":"12","author":"GO Shabestari","year":"2010","unstructured":"Shabestari GO, Shayesteh YS, Khojasteh A, Alikhasi M, Moslemi N, Aminian A, Masaeli R, Eslami B, Treister NS (2010) Implant placement in patients with oral bisphosphonate therapy: a case series. Clin Implant Dent Relat Res 12:175\u2013180","journal-title":"Clin Implant Dent Relat Res"},{"key":"2579_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/BLO.0b013e31813c6696","volume":"463","author":"T Jakobsen","year":"2007","unstructured":"Jakobsen T, Baas J, Bechtold JE, Elmengaard B, Soballe K (2007) Soaking morselized allograft in bisphosphonate can impair implant fixation. Clin Orthop Relat Res 463:195\u2013201","journal-title":"Clin Orthop Relat Res"},{"key":"2579_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1563\/AAID-JOI-D-09-00114","volume":"37","author":"TM Zahid","year":"2011","unstructured":"Zahid TM, Wang BY, Cohen RE (2011) Influence of bisphosphonates on alveolar bone loss around osseointegrated implants. J Oral Implantol 37:335\u2013346","journal-title":"J Oral Implantol"},{"key":"2579_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/19424396.2009.12222946","volume":"37","author":"T Kasai","year":"2009","unstructured":"Kasai T, Pogrel MA, Hossaini M (2009) The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc 37:39\u201342","journal-title":"J Calif Dent Assoc"},{"key":"2579_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1902\/jop.2005.76.1.107","volume":"76","author":"PM Duarte","year":"2005","unstructured":"Duarte PM, de Vasconcelos Gurgel BC, Sallum AW, Filho GR, Sallum EA, Nociti FH Jr (2005) Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats. J Periodontol 76:107\u2013114","journal-title":"J Periodontol"},{"key":"2579_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tripleo.2007.06.010","volume":"105","author":"G Giro","year":"2008","unstructured":"Giro G, Goncalves D, Sakakura CE, Pereira RM, Marcantonio Junior E, Orrico SR (2008) Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:162\u2013167","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2579_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S8756-3282(98)00033-7","volume":"22","author":"N Giuliani","year":"1998","unstructured":"Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G (1998) Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22:455\u2013461","journal-title":"Bone"},{"key":"2579_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1359\/jbmr.070906","volume":"23","author":"RR Recker","year":"2008","unstructured":"Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garcia-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF (2008) Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 23:6\u201316","journal-title":"J Bone Miner Res"},{"key":"2579_CR21","volume-title":"J Orthop Res","author":"T Jakobsen","year":"2016","unstructured":"Jakobsen T, Bechtold JE, Soballe K, Jensen T, Vestermark MT, Baas J (2016) Local delivery of zoledronate from a poly (D,L-lactide)-coating increases fixation of hydroxy-coated implants. In: J Orthop Res"},{"key":"2579_CR22","doi-asserted-by":"crossref","unstructured":"Kettenberger U, Luginbuehl V, Procter P, Pioletti DP (2015) In vitro and in vivo investigation of bisphosphonate-loaded hydroxyapatite particles for peri-implant bone augmentation. J Tissue Eng Regen Med","DOI":"10.1002\/term.2094"},{"key":"2579_CR23","volume-title":"America\u2019s bone health: the state of osteoporosis and low bone mass","author":"National Osteoporosis Foundation","year":"2002","unstructured":"National Osteoporosis Foundation (2002) America\u2019s bone health: the state of osteoporosis and low bone mass. National Osteoporosis Foundation, Washington DC"},{"key":"2579_CR24","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.14219\/jada.archive.2006.0355","volume":"137","author":"ADACS Affairs","year":"2006","unstructured":"Affairs ADACS (2006) Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 137:1144\u20131150","journal-title":"J Am Dent Assoc"},{"key":"2579_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10266-010-0153-0","volume":"99","author":"MR Allen","year":"2011","unstructured":"Allen MR (2011) The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing. Odontology 99:8\u201317","journal-title":"Odontology"},{"key":"2579_CR26","unstructured":"Marx R (2007) Oral and intravenous bisphosphonate induced osteonecrosis of the jaws: history, etiology, prevention, and treatment. Chicago"},{"key":"2579_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"2579_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000151371","volume":"189","author":"MR Allen","year":"2009","unstructured":"Allen MR (2009) Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench. Cells Tissues Organs 189:289\u2013294","journal-title":"Cells Tissues Organs"},{"key":"2579_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00198-008-0717-9","volume":"20","author":"T Diab","year":"2009","unstructured":"Diab T, Allen MR, Burr DB (2009) Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra. Osteoporos Int 20:647\u2013652","journal-title":"Osteoporos Int"},{"key":"2579_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1359\/jbmr.090713","volume":"25","author":"MR Allen","year":"2010","unstructured":"Allen MR, Kubek DJ, Burr DB (2010) Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. J Bone Miner Res 25:98\u2013105","journal-title":"J Bone Miner Res"},{"key":"2579_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","volume":"66","author":"MR Allen","year":"2008","unstructured":"Allen MR, Burr DB (2008) Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 66:987\u2013994","journal-title":"J Oral Maxillofac Surg"},{"key":"2579_CR32","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.tripleo.2007.04.022","volume":"104","author":"S Srisubut","year":"2007","unstructured":"Srisubut S, Teerakapong A, Vattraphodes T, Taweechaisupapong S (2007) Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:e11\u2013e16","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2579_CR33","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/clr.12483","volume":"26","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Stavropoulos A, Calvo-Guirado JL, Schneider D, Fickl S (2015) Influence of local administration of pamidronate on extraction socket healing--a histomorphometric proof-of-principle pre-clinical in vivo evaluation. Clin Oral Implants Res 26:1135\u20131142","journal-title":"Clin Oral Implants Res"},{"key":"2579_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/jor.20272","volume":"25","author":"TB Jensen","year":"2007","unstructured":"Jensen TB, Bechtold JE, Chen X, Soballe K (2007) Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants. J Orthop Res 25:772\u2013778","journal-title":"J Orthop Res"},{"key":"2579_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00784-013-0951-1","volume":"18","author":"P Taxel","year":"2014","unstructured":"Taxel P, Ortiz D, Shafer D, Pendrys D, Reisine S, Rengasamy K, Freilich M (2014) The relationship between implant stability and bone health markers in post-menopausal women with bisphosphonate exposure. Clin Oral Investig 18:49\u201357","journal-title":"Clin Oral Investig"},{"key":"2579_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613\u2013620","journal-title":"J Bone Miner Res"},{"key":"2579_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.bone.2005.07.023","volume":"38","author":"CT Leu","year":"2006","unstructured":"Leu CT, Luegmayr E, Freedman LP, Rodan GA, Reszka AA (2006) Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy. Bone 38:628\u2013636","journal-title":"Bone"},{"key":"2579_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10561-013-9416-7","volume":"15","author":"N Mathijssen","year":"2014","unstructured":"Mathijssen N, Buma P, Hannink G (2014) Combining bisphosphonates with allograft bone for implant fixation. Cell Tissue Bank 15:329\u2013336","journal-title":"Cell Tissue Bank"},{"key":"2579_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11999-013-3120-6","volume":"472","author":"JD Bobyn","year":"2014","unstructured":"Bobyn JD, Thompson R, Lim L, Pura JA, Bobyn K, Tanzer M (2014) Local alendronic acid elution increases net periimplant bone formation: a micro-CT analysis. Clin Orthop Relat Res 472:687\u2013694","journal-title":"Clin Orthop Relat Res"},{"key":"2579_CR40","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s11999-016-4714-6","volume":"474","author":"JA Pura","year":"2016","unstructured":"Pura JA, Bobyn JD, Tanzer M (2016) Implant-delivered alendronate causes a dose-dependent response on net bone formation around porous titanium implants in canines. Clin Orthop Relat Res 474:1224\u20131233","journal-title":"Clin Orthop Relat Res"},{"key":"2579_CR41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11999-009-1099-9","volume":"468","author":"T Jakobsen","year":"2010","unstructured":"Jakobsen T, Baas J, Bechtold JE, Elmengaard B, Soballe K (2010) The effect of soaking allograft in bisphosphonate: a pilot dose-response study. Clin Orthop Relat Res 468:867\u2013874","journal-title":"Clin Orthop Relat Res"},{"key":"2579_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","volume":"49","author":"T Bellido","year":"2011","unstructured":"Bellido T, Plotkin LI (2011) Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone 49:50\u201355","journal-title":"Bone"},{"key":"2579_CR43","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx RE, Cillo JE, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65:2397\u20132410","journal-title":"J Oral Maxillofac Surg"},{"key":"2579_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1749-6632.2010.05770.x","volume":"1218","author":"S Cremers","year":"2011","unstructured":"Cremers S, Farooki A (2011) Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone. Ann N Y Acad Sci 1218:80\u201387","journal-title":"Ann N Y Acad Sci"},{"key":"2579_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/ID.0b013e3181cec8bc","volume":"19","author":"CY Lee","year":"2010","unstructured":"Lee CY, Suzuki JB (2010) CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study. Implant Dent 19:29\u201338","journal-title":"Implant Dent"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-018-2579-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:04:57Z","timestamp":1720566297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-018-2579-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2579"],"URL":"https:\/\/doi.org\/10.1007\/s00784-018-2579-7","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"type":"print","value":"1432-6981"},{"type":"electronic","value":"1436-3771"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"31 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}